Retiform Purpura in the Setting of COVID-19: A Harbinger of Underlying Coagulopathy and Severe Disease Course

While the majority of COVID-19 cases are mild and can be managed in the outpatient setting, more severe cases have proven to be a clinical challenge. While some cases demonstrate a more slow and indolent decline, others seem to deteriorate rapidly with little forewarning. The current literature has...

Full description

Saved in:
Bibliographic Details
Published inSkin (Milwood, N.Y.) Vol. 5; no. 4; pp. 434 - 436
Main Authors Brody, Gabrielle, Nguyen, Michael O., Foulad, Delila Pouldar, Rojek, Nathan W.
Format Journal Article
LanguageEnglish
Published 09.07.2021
Online AccessGet full text

Cover

More Information
Summary:While the majority of COVID-19 cases are mild and can be managed in the outpatient setting, more severe cases have proven to be a clinical challenge. While some cases demonstrate a more slow and indolent decline, others seem to deteriorate rapidly with little forewarning. The current literature has connected Retiform Purpura as a cutaneous manifestation associated with severe COVID-19 infections, however timing of cutaneous presentation and severe clinical COVID-19 symptoms has not been well described. Here we report a case of a 58-year-old female who developed Retiform Purpura nearly a week prior to the development of any significant COVID-19 symptoms. This case demonstrates that Retiform Purpura is not only associated with severe COVID-19 disease, but can present prior to symptom onset and should be seen as a harbinger for impending clinical deterioration.
ISSN:2574-1624
2574-1624
DOI:10.25251/skin.5.4.18